Voloridge Investment Management, LLC Adc Therapeutics Sa Transaction History

Voloridge Investment Management, LLC

  • $26.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$19.29 - $31.51 $595,038 - $971,988
-30,847 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$20.45 - $30.0 $978,103 - $1.43 Million
-47,829 Reduced 60.79%
30,847 $838,000
Q2 2021

Aug 16, 2021
BUY
$20.38 - $27.04 $935,482 - $1.24 Million
45,902 Added 140.06%
78,676 $1.92 Million
Q1 2021

May 17, 2021
BUY
$22.75 - $34.05 $745,608 - $1.12 Million
32,774 New
32,774 $800,000

Others Institutions Holding ADCT

# of Institutions
80
Shares Held
55.1M
Call Options Held
82.7K
Put Options Held
31.5K
View Full List

About ADC Therapeutics SA

ADCT Quotes by TradingView
  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $175M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email